Overall survival (OS) analysis revealed that RBMX was a protective factor in patients suffering from cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), KIRC, rectum adenocarcinoma (READ), THYM, UCS, and uveal melanoma (UVM). Here, RBMX is linked to thymoma.